However, changes in MALAT1 expression have also been observed in other types of diseases, such as hyperglycemia, diabetic retinopathy, proliferative vitreoretinopathy, liver fibrosis, and hypertension. Here, MALAT1 is linked to CAPN5-related vitreoretinopathy.